Apr 29, 2026
Apr 29, 2026
Apr 29, 2026
Apr 29, 2026
Apr 29, 2026
Apr 29, 2026
Apr 29, 2026
Apr 29, 2026
Dianthus Therapeutics CFO Ryan Savitz sold 8,224 shares, raking in $739,000. What does this insider sale mean for investors and the biotech sector?